NO20072687L - Farmasoytisk prevensjonspreparat - Google Patents
Farmasoytisk prevensjonspreparatInfo
- Publication number
- NO20072687L NO20072687L NO20072687A NO20072687A NO20072687L NO 20072687 L NO20072687 L NO 20072687L NO 20072687 A NO20072687 A NO 20072687A NO 20072687 A NO20072687 A NO 20072687A NO 20072687 L NO20072687 L NO 20072687L
- Authority
- NO
- Norway
- Prior art keywords
- daily dosage
- ethinyl estradiol
- administered
- dienogest
- pharmaceutically acceptable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Organic Chemistry (AREA)
- Reproductive Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
Abstract
Oppfinnelsen vedrører et farmasøytisk preparat som inneholder dienogest ved en mengde som tilsvarer en daglig doseringsenhet på 1,5 mg eller 2,0 mg når preparatet blir administrert, og etinyløstradiol ved en mengde som tilsvarer en daglig doseringsenhet på 0,015 mg eller 0,020 mg når preparatet blir administrert, sammen med én eller flere farmasøytisk akseptable bærere i minst 21 daglige doseringsenheter. Oppfinnelsen vedrører ytterligere et oralt, farmasøytisk prevensjonspreparat inneholdende 1,5 mg 17a-cyanometyl-17ß-hydroksyøstra-4,9-dien-3-on (dienogest) og 0,015 eller 0,020 mg 17a-etinyløstradiol (etinyløstradiol) eller 2,0 mg dienogest og 0,015 mg etinyløstradiol sammen med én eller flere farmasøytisk akseptable bærer i minst 21 daglige doseringsenheter i en 28-dagers menstruasjonssyklus.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05003179A EP1690543A1 (de) | 2005-02-15 | 2005-02-15 | Pharmazeutisches Präparat zur Kontrazeption |
PCT/EP2006/001354 WO2006087173A1 (de) | 2005-02-15 | 2006-02-15 | Pharmazeutisches präparat zur kontrazeption |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20072687L true NO20072687L (no) | 2007-11-13 |
Family
ID=34933759
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20072687A NO20072687L (no) | 2005-02-15 | 2007-05-25 | Farmasoytisk prevensjonspreparat |
Country Status (20)
Country | Link |
---|---|
EP (2) | EP1690543A1 (no) |
JP (1) | JP2008527018A (no) |
KR (1) | KR20070086380A (no) |
CN (1) | CN101119732A (no) |
AR (1) | AR053545A1 (no) |
AU (1) | AU2006215818A1 (no) |
BR (1) | BRPI0606724A2 (no) |
CA (1) | CA2590004A1 (no) |
CR (1) | CR9324A (no) |
DO (1) | DOP2006000035A (no) |
EA (1) | EA200701091A1 (no) |
IL (1) | IL183635A0 (no) |
MX (1) | MX2007009061A (no) |
NO (1) | NO20072687L (no) |
PA (1) | PA8663401A1 (no) |
PE (1) | PE20061291A1 (no) |
TW (1) | TW200640468A (no) |
UA (1) | UA85003C2 (no) |
WO (1) | WO2006087173A1 (no) |
ZA (1) | ZA200707910B (no) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1774970A1 (de) * | 2005-10-13 | 2007-04-18 | Bayer Schering Pharma AG | Verfahren zur Herstellung eines einphasigen pharmazeutischen Präparates zur Therapie der dysfunktionellen uterinen Blutung, enthaltend Ethinylestradiol und Dienogest |
EP2209475A2 (de) * | 2007-10-11 | 2010-07-28 | Bayer Schering Pharma Aktiengesellschaft | Verfahren zur herstellung eines einphasischen pharmazeutischen präparates zur begrenzung/minderung des risikos einer tiefen-venen-thrombose in einheit mit einer oralen kontrazeption |
AT12800U1 (de) * | 2007-11-05 | 2012-11-15 | Bayer Schering Pharma Ag | Pharmazeutisches Präparat zur Verwendung bei der oralen Kontrazeption von Frauen mit Laktoseintoleranz |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100518102B1 (ko) * | 1996-07-26 | 2005-10-04 | 와이어쓰 | 프로게스틴과 에스트로겐의 혼합물을 포함하는 단일상 피임약 키트 |
-
2005
- 2005-02-15 EP EP05003179A patent/EP1690543A1/de not_active Withdrawn
-
2006
- 2006-02-13 DO DO2006000035A patent/DOP2006000035A/es unknown
- 2006-02-15 EA EA200701091A patent/EA200701091A1/ru unknown
- 2006-02-15 PA PA20068663401A patent/PA8663401A1/es unknown
- 2006-02-15 EP EP06706958A patent/EP1853273A1/de not_active Ceased
- 2006-02-15 JP JP2007551646A patent/JP2008527018A/ja not_active Withdrawn
- 2006-02-15 CA CA002590004A patent/CA2590004A1/en not_active Abandoned
- 2006-02-15 MX MX2007009061A patent/MX2007009061A/es not_active Application Discontinuation
- 2006-02-15 AU AU2006215818A patent/AU2006215818A1/en not_active Abandoned
- 2006-02-15 WO PCT/EP2006/001354 patent/WO2006087173A1/de active Application Filing
- 2006-02-15 UA UAA200709517A patent/UA85003C2/ru unknown
- 2006-02-15 TW TW095105106A patent/TW200640468A/zh unknown
- 2006-02-15 CN CNA2006800048911A patent/CN101119732A/zh active Pending
- 2006-02-15 AR ARP060100527A patent/AR053545A1/es unknown
- 2006-02-15 KR KR1020077013786A patent/KR20070086380A/ko not_active Application Discontinuation
- 2006-02-15 BR BRPI0606724-7A patent/BRPI0606724A2/pt not_active IP Right Cessation
- 2006-02-15 PE PE2006000182A patent/PE20061291A1/es not_active Application Discontinuation
-
2007
- 2007-05-25 NO NO20072687A patent/NO20072687L/no not_active Application Discontinuation
- 2007-06-04 IL IL183635A patent/IL183635A0/en unknown
- 2007-08-17 CR CR9324A patent/CR9324A/es unknown
- 2007-09-14 ZA ZA200707910A patent/ZA200707910B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
BRPI0606724A2 (pt) | 2009-07-14 |
JP2008527018A (ja) | 2008-07-24 |
AR053545A1 (es) | 2007-05-09 |
UA85003C2 (ru) | 2008-12-10 |
CR9324A (es) | 2007-10-11 |
EP1853273A1 (de) | 2007-11-14 |
MX2007009061A (es) | 2007-09-11 |
EA200701091A1 (ru) | 2008-02-28 |
EP1690543A1 (de) | 2006-08-16 |
CA2590004A1 (en) | 2006-08-24 |
ZA200707910B (en) | 2009-08-26 |
KR20070086380A (ko) | 2007-08-27 |
TW200640468A (en) | 2006-12-01 |
PE20061291A1 (es) | 2006-12-07 |
CN101119732A (zh) | 2008-02-06 |
IL183635A0 (en) | 2007-10-31 |
PA8663401A1 (es) | 2006-12-07 |
DOP2006000035A (es) | 2006-09-15 |
AU2006215818A1 (en) | 2006-08-24 |
WO2006087173A1 (de) | 2006-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20070188B1 (hr) | Farmaceutska kombinacija etinilestradiola i drospirenona za upotrebu kao kontracepcijskog sredstva | |
EA200900491A1 (ru) | Применение эстрадиола валерата или 17в-эстрадиола в комбинации с диеногестом для перорального лечения для поддержания и/или повышения полового влечения у особи женского пола | |
RS50972B (sr) | Farmaceutski sastav koji sadrži gestagene i/ili estrogene i 5-metil-(6s)-tetrahidrofolate | |
NO327588B1 (no) | Farmasoytisk sammensetning og preparat omfattende etinylostradiol og drospirenon for anvendelse som antikonsepsjonsmiddel | |
WO2005092441A3 (en) | Extended cycle multiphasic oral contraceptive method | |
NO20072687L (no) | Farmasoytisk prevensjonspreparat | |
EA200701389A1 (ru) | Твёрдая пероральная лекарственная форма для контрацепции | |
HRP20090256T1 (en) | Use of estradiolvalerate and dienogest for oral treatment of dysfunctional uterine bleeding in a contraceptive method | |
TW200638951A (en) | Solid oral pharmaceutical form for contraception | |
WO2008017331A3 (de) | Perorale arzneiform mit dienogest und ethinylestradiol zur kontrazeption | |
PL1937274T3 (pl) | Zastosowanie walerianianu estradiolu w połączeniu z dienogestem do doustnej terapii dysfunkcyjnego krwawienia macicznego wraz z doustną antykoncepcją | |
UY29378A1 (es) | Preparación farmaceutica para la anticoncepción oral | |
RS50849B (sr) | Upotreba estradiolvalerata i dienogesta za oralno lečenje disfunkcionalnog uterinog krvarenja u kontracepcijskom metodu | |
JO2213B1 (en) | A pharmaceutical composition for use as a contraceptive method | |
HRP20020666B1 (en) | Drospirenone for hormone replacement therapy | |
RU2009140372A (ru) | Новый режим с дроспиреноном/17b-эстрадиолом, фармацевтический комбинированный продукт и набор для выполнения этого режима | |
TH80558B (th) | รูปแบบยาทางช่องปากชนิดแข็งสำหรับการคุมกำเนิด | |
TH54054B (th) | สารผสมทางเภสัชกรรมสำหรับใช้เป็นยาคุมกำเนิด | |
TH148141A (th) | การใช้เอสตราไดออลวาเลอเรตหรือเอสตราไดออลร่วมกับไดอีโนเจสต์สำหรับการรักษาโดยให้ทางปากในการตกเลือดในมดลูกแบบที่ทำงานผิดปกติ ร่วมกับยาคุมกำเนิดสำหรับให้ทางปาก |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |